nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Progesterone—uterine cancer	0.0974	0.284	CbGbCtD
Paliperidone—CYP2D6—Progesterone—uterine cancer	0.0597	0.174	CbGbCtD
Paliperidone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0573	0.167	CbGbCtD
Paliperidone—CYP3A5—Etoposide—uterine cancer	0.0436	0.127	CbGbCtD
Paliperidone—CYP3A4—Progesterone—uterine cancer	0.038	0.111	CbGbCtD
Paliperidone—CYP2D6—Doxorubicin—uterine cancer	0.0182	0.0532	CbGbCtD
Paliperidone—CYP3A4—Etoposide—uterine cancer	0.017	0.0496	CbGbCtD
Paliperidone—CYP3A4—Doxorubicin—uterine cancer	0.0116	0.0338	CbGbCtD
Paliperidone—HTR1B—artery—uterine cancer	0.00491	0.0775	CbGeAlD
Paliperidone—HTR1D—artery—uterine cancer	0.00475	0.0751	CbGeAlD
Paliperidone—HTR2A—artery—uterine cancer	0.00236	0.0373	CbGeAlD
Paliperidone—ADRA1B—renal system—uterine cancer	0.00229	0.0361	CbGeAlD
Paliperidone—ADRA2C—myometrium—uterine cancer	0.00168	0.0266	CbGeAlD
Paliperidone—HTR1A—renal system—uterine cancer	0.00139	0.022	CbGeAlD
Paliperidone—ADRA1A—epithelium—uterine cancer	0.00139	0.0219	CbGeAlD
Paliperidone—HTR1B—female reproductive system—uterine cancer	0.00138	0.0218	CbGeAlD
Paliperidone—HRH1—myometrium—uterine cancer	0.00137	0.0216	CbGeAlD
Paliperidone—ADRA2A—myometrium—uterine cancer	0.00134	0.0212	CbGeAlD
Paliperidone—HTR1D—female reproductive system—uterine cancer	0.00134	0.0211	CbGeAlD
Paliperidone—HTR2C—female reproductive system—uterine cancer	0.00133	0.0209	CbGeAlD
Paliperidone—ADRA2C—uterine cervix—uterine cancer	0.00131	0.0207	CbGeAlD
Paliperidone—ADRA1A—renal system—uterine cancer	0.00128	0.0203	CbGeAlD
Paliperidone—ADRA2C—decidua—uterine cancer	0.00125	0.0197	CbGeAlD
Paliperidone—ADRA2C—renal system—uterine cancer	0.00122	0.0193	CbGeAlD
Paliperidone—ADRA2C—endometrium—uterine cancer	0.00118	0.0187	CbGeAlD
Paliperidone—ADRA2C—mammalian vulva—uterine cancer	0.00114	0.0181	CbGeAlD
Paliperidone—CYP3A5—uterine cervix—uterine cancer	0.0011	0.0173	CbGeAlD
Paliperidone—ADRA2C—uterus—uterine cancer	0.00109	0.0172	CbGeAlD
Paliperidone—HRH1—epithelium—uterine cancer	0.00107	0.0169	CbGeAlD
Paliperidone—HRH1—uterine cervix—uterine cancer	0.00106	0.0168	CbGeAlD
Paliperidone—ADRA2A—uterine cervix—uterine cancer	0.00104	0.0165	CbGeAlD
Paliperidone—HRH1—smooth muscle tissue—uterine cancer	0.00103	0.0163	CbGeAlD
Paliperidone—CYP3A5—renal system—uterine cancer	0.00102	0.0162	CbGeAlD
Paliperidone—HRH1—decidua—uterine cancer	0.00101	0.016	CbGeAlD
Paliperidone—ADRA2A—decidua—uterine cancer	0.000995	0.0157	CbGeAlD
Paliperidone—HRH1—endometrium—uterine cancer	0.000961	0.0152	CbGeAlD
Paliperidone—ADRA2A—endometrium—uterine cancer	0.000944	0.0149	CbGeAlD
Paliperidone—HRH1—mammalian vulva—uterine cancer	0.00093	0.0147	CbGeAlD
Paliperidone—ADRA2A—mammalian vulva—uterine cancer	0.000914	0.0144	CbGeAlD
Paliperidone—HTR2A—epithelium—uterine cancer	0.000895	0.0141	CbGeAlD
Paliperidone—ADRA2C—female gonad—uterine cancer	0.000892	0.0141	CbGeAlD
Paliperidone—ADRA2C—vagina—uterine cancer	0.000887	0.014	CbGeAlD
Paliperidone—ADRA2A—uterus—uterine cancer	0.00087	0.0137	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—uterine cancer	0.000863	0.0136	CbGeAlD
Paliperidone—HTR2A—renal system—uterine cancer	0.000831	0.0131	CbGeAlD
Paliperidone—HRH1—female reproductive system—uterine cancer	0.000796	0.0126	CbGeAlD
Paliperidone—ADRA2A—female reproductive system—uterine cancer	0.000782	0.0124	CbGeAlD
Paliperidone—CYP3A4—renal system—uterine cancer	0.000769	0.0121	CbGeAlD
Paliperidone—CYP2D6—renal system—uterine cancer	0.000757	0.0119	CbGeAlD
Paliperidone—CYP3A5—female gonad—uterine cancer	0.000747	0.0118	CbGeAlD
Paliperidone—CYP3A5—vagina—uterine cancer	0.000742	0.0117	CbGeAlD
Paliperidone—HRH1—female gonad—uterine cancer	0.000725	0.0114	CbGeAlD
Paliperidone—HRH1—vagina—uterine cancer	0.00072	0.0114	CbGeAlD
Paliperidone—ADRA2A—female gonad—uterine cancer	0.000712	0.0112	CbGeAlD
Paliperidone—ADRA2A—vagina—uterine cancer	0.000708	0.0112	CbGeAlD
Paliperidone—HTR2A—female reproductive system—uterine cancer	0.000665	0.0105	CbGeAlD
Paliperidone—CYP3A4—female reproductive system—uterine cancer	0.000616	0.00972	CbGeAlD
Paliperidone—CYP2D6—female reproductive system—uterine cancer	0.000606	0.00957	CbGeAlD
Paliperidone—HTR2A—vagina—uterine cancer	0.000602	0.0095	CbGeAlD
Paliperidone—ADRA2C—lymph node—uterine cancer	0.000574	0.00906	CbGeAlD
Paliperidone—CYP2D6—female gonad—uterine cancer	0.000551	0.00871	CbGeAlD
Paliperidone—HRH1—lymph node—uterine cancer	0.000466	0.00736	CbGeAlD
Paliperidone—ADRA2A—lymph node—uterine cancer	0.000458	0.00723	CbGeAlD
Paliperidone—Cardiac arrest—Doxorubicin—uterine cancer	0.000304	0.000513	CcSEcCtD
Paliperidone—Anaphylactic shock—Etoposide—uterine cancer	0.000303	0.000511	CcSEcCtD
Paliperidone—Infection—Etoposide—uterine cancer	0.000301	0.000507	CcSEcCtD
Paliperidone—Asthenia—Dactinomycin—uterine cancer	0.000301	0.000506	CcSEcCtD
Paliperidone—Influenza—Epirubicin—uterine cancer	0.000299	0.000504	CcSEcCtD
Paliperidone—Dysphagia—Epirubicin—uterine cancer	0.000299	0.000504	CcSEcCtD
Paliperidone—Thrombocytopenia—Etoposide—uterine cancer	0.000297	0.0005	CcSEcCtD
Paliperidone—Tachycardia—Etoposide—uterine cancer	0.000296	0.000499	CcSEcCtD
Paliperidone—Skin disorder—Etoposide—uterine cancer	0.000295	0.000496	CcSEcCtD
Paliperidone—Dry skin—Doxorubicin—uterine cancer	0.000293	0.000494	CcSEcCtD
Paliperidone—Pancreatitis—Epirubicin—uterine cancer	0.000293	0.000494	CcSEcCtD
Paliperidone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000292	0.000492	CcSEcCtD
Paliperidone—Abdominal pain upper—Doxorubicin—uterine cancer	0.000292	0.000492	CcSEcCtD
Paliperidone—Breast disorder—Doxorubicin—uterine cancer	0.000289	0.000487	CcSEcCtD
Paliperidone—Anorexia—Etoposide—uterine cancer	0.000289	0.000487	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000288	0.000485	CcSEcCtD
Paliperidone—Bronchitis—Epirubicin—uterine cancer	0.000288	0.000484	CcSEcCtD
Paliperidone—Diarrhoea—Dactinomycin—uterine cancer	0.000287	0.000483	CcSEcCtD
Paliperidone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000286	0.000482	CcSEcCtD
Paliperidone—Hypotension—Etoposide—uterine cancer	0.000283	0.000477	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000282	0.000475	CcSEcCtD
Paliperidone—Muscular weakness—Doxorubicin—uterine cancer	0.000282	0.000475	CcSEcCtD
Paliperidone—Neutropenia—Epirubicin—uterine cancer	0.00028	0.000471	CcSEcCtD
Paliperidone—Dysuria—Epirubicin—uterine cancer	0.00028	0.000471	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000278	0.000468	CcSEcCtD
Paliperidone—Influenza—Doxorubicin—uterine cancer	0.000277	0.000466	CcSEcCtD
Paliperidone—Dysphagia—Doxorubicin—uterine cancer	0.000277	0.000466	CcSEcCtD
Paliperidone—Pollakiuria—Epirubicin—uterine cancer	0.000276	0.000465	CcSEcCtD
Paliperidone—Paraesthesia—Etoposide—uterine cancer	0.000272	0.000459	CcSEcCtD
Paliperidone—Weight increased—Epirubicin—uterine cancer	0.000272	0.000458	CcSEcCtD
Paliperidone—Pancreatitis—Doxorubicin—uterine cancer	0.000271	0.000457	CcSEcCtD
Paliperidone—Weight decreased—Epirubicin—uterine cancer	0.000271	0.000456	CcSEcCtD
Paliperidone—Dyspnoea—Etoposide—uterine cancer	0.00027	0.000455	CcSEcCtD
Paliperidone—Hyperglycaemia—Epirubicin—uterine cancer	0.00027	0.000454	CcSEcCtD
Paliperidone—Somnolence—Etoposide—uterine cancer	0.00027	0.000454	CcSEcCtD
Paliperidone—Pneumonia—Epirubicin—uterine cancer	0.000268	0.000452	CcSEcCtD
Paliperidone—Infestation—Epirubicin—uterine cancer	0.000267	0.000449	CcSEcCtD
Paliperidone—Infestation NOS—Epirubicin—uterine cancer	0.000267	0.000449	CcSEcCtD
Paliperidone—Vomiting—Dactinomycin—uterine cancer	0.000267	0.000449	CcSEcCtD
Paliperidone—Bronchitis—Doxorubicin—uterine cancer	0.000266	0.000448	CcSEcCtD
Paliperidone—Rash—Dactinomycin—uterine cancer	0.000264	0.000445	CcSEcCtD
Paliperidone—Decreased appetite—Etoposide—uterine cancer	0.000264	0.000444	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000262	0.000441	CcSEcCtD
Paliperidone—Fatigue—Etoposide—uterine cancer	0.000262	0.00044	CcSEcCtD
Paliperidone—Jaundice—Epirubicin—uterine cancer	0.00026	0.000438	CcSEcCtD
Paliperidone—Pain—Etoposide—uterine cancer	0.000259	0.000437	CcSEcCtD
Paliperidone—Constipation—Etoposide—uterine cancer	0.000259	0.000437	CcSEcCtD
Paliperidone—Conjunctivitis—Epirubicin—uterine cancer	0.000259	0.000436	CcSEcCtD
Paliperidone—Urinary tract infection—Epirubicin—uterine cancer	0.000259	0.000436	CcSEcCtD
Paliperidone—Dysuria—Doxorubicin—uterine cancer	0.000259	0.000436	CcSEcCtD
Paliperidone—Neutropenia—Doxorubicin—uterine cancer	0.000259	0.000436	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000257	0.000433	CcSEcCtD
Paliperidone—Pollakiuria—Doxorubicin—uterine cancer	0.000256	0.00043	CcSEcCtD
Paliperidone—Hepatobiliary disease—Epirubicin—uterine cancer	0.000252	0.000425	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—uterine cancer	0.000252	0.000424	CcSEcCtD
Paliperidone—Epistaxis—Epirubicin—uterine cancer	0.000251	0.000423	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—uterine cancer	0.00025	0.000422	CcSEcCtD
Paliperidone—Sinusitis—Epirubicin—uterine cancer	0.00025	0.000421	CcSEcCtD
Paliperidone—Feeling abnormal—Etoposide—uterine cancer	0.00025	0.000421	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—uterine cancer	0.00025	0.00042	CcSEcCtD
Paliperidone—Nausea—Dactinomycin—uterine cancer	0.000249	0.000419	CcSEcCtD
Paliperidone—Agranulocytosis—Epirubicin—uterine cancer	0.000249	0.000419	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—uterine cancer	0.000248	0.000418	CcSEcCtD
Paliperidone—Gastrointestinal pain—Etoposide—uterine cancer	0.000248	0.000418	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—uterine cancer	0.000247	0.000415	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—uterine cancer	0.000247	0.000415	CcSEcCtD
Paliperidone—Bradycardia—Epirubicin—uterine cancer	0.000244	0.00041	CcSEcCtD
Paliperidone—Urticaria—Etoposide—uterine cancer	0.000241	0.000406	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—uterine cancer	0.00024	0.000405	CcSEcCtD
Paliperidone—Rhinitis—Epirubicin—uterine cancer	0.00024	0.000404	CcSEcCtD
Paliperidone—Abdominal pain—Etoposide—uterine cancer	0.00024	0.000404	CcSEcCtD
Paliperidone—Body temperature increased—Etoposide—uterine cancer	0.00024	0.000404	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—uterine cancer	0.00024	0.000404	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—uterine cancer	0.00024	0.000404	CcSEcCtD
Paliperidone—Hypoaesthesia—Epirubicin—uterine cancer	0.000238	0.000401	CcSEcCtD
Paliperidone—Urinary tract disorder—Epirubicin—uterine cancer	0.000236	0.000398	CcSEcCtD
Paliperidone—Oedema peripheral—Epirubicin—uterine cancer	0.000236	0.000397	CcSEcCtD
Paliperidone—Connective tissue disorder—Epirubicin—uterine cancer	0.000235	0.000396	CcSEcCtD
Paliperidone—Urethral disorder—Epirubicin—uterine cancer	0.000235	0.000395	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000233	0.000393	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—uterine cancer	0.000233	0.000392	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—uterine cancer	0.000231	0.00039	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—uterine cancer	0.00023	0.000388	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—uterine cancer	0.000225	0.00038	CcSEcCtD
Paliperidone—Eye disorder—Epirubicin—uterine cancer	0.000224	0.000377	CcSEcCtD
Paliperidone—Hypersensitivity—Etoposide—uterine cancer	0.000224	0.000376	CcSEcCtD
Paliperidone—Tinnitus—Epirubicin—uterine cancer	0.000223	0.000376	CcSEcCtD
Paliperidone—Flushing—Epirubicin—uterine cancer	0.000222	0.000374	CcSEcCtD
Paliperidone—Cardiac disorder—Epirubicin—uterine cancer	0.000222	0.000374	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—uterine cancer	0.000222	0.000374	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—uterine cancer	0.00022	0.000371	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000219	0.000368	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—uterine cancer	0.000218	0.000367	CcSEcCtD
Paliperidone—Asthenia—Etoposide—uterine cancer	0.000218	0.000367	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000218	0.000366	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—uterine cancer	0.000217	0.000366	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—uterine cancer	0.000217	0.000366	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—uterine cancer	0.000216	0.000364	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—uterine cancer	0.000216	0.000363	CcSEcCtD
Paliperidone—Chills—Epirubicin—uterine cancer	0.000215	0.000362	CcSEcCtD
Paliperidone—Pruritus—Etoposide—uterine cancer	0.000215	0.000361	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—uterine cancer	0.000212	0.000356	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—uterine cancer	0.00021	0.000353	CcSEcCtD
Paliperidone—Erythema—Epirubicin—uterine cancer	0.000208	0.000351	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—uterine cancer	0.000208	0.000351	CcSEcCtD
Paliperidone—Diarrhoea—Etoposide—uterine cancer	0.000208	0.00035	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—uterine cancer	0.000207	0.000349	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—uterine cancer	0.000206	0.000348	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—uterine cancer	0.000206	0.000346	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—uterine cancer	0.000206	0.000346	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—uterine cancer	0.000205	0.000346	CcSEcCtD
Paliperidone—Tension—Epirubicin—uterine cancer	0.000204	0.000344	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—uterine cancer	0.000204	0.000344	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—uterine cancer	0.000202	0.000341	CcSEcCtD
Paliperidone—Back pain—Epirubicin—uterine cancer	0.000202	0.000339	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—uterine cancer	0.000201	0.000338	CcSEcCtD
Paliperidone—Dizziness—Etoposide—uterine cancer	0.000201	0.000338	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—uterine cancer	0.0002	0.000337	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—uterine cancer	0.0002	0.000337	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—uterine cancer	0.0002	0.000336	CcSEcCtD
Paliperidone—Chills—Doxorubicin—uterine cancer	0.000199	0.000335	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—uterine cancer	0.000196	0.000331	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—uterine cancer	0.000196	0.00033	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—uterine cancer	0.000194	0.000327	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—uterine cancer	0.000193	0.000326	CcSEcCtD
Paliperidone—Vomiting—Etoposide—uterine cancer	0.000193	0.000325	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—uterine cancer	0.000193	0.000325	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—uterine cancer	0.000193	0.000325	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—uterine cancer	0.000193	0.000324	CcSEcCtD
Paliperidone—Agitation—Epirubicin—uterine cancer	0.000191	0.000322	CcSEcCtD
Paliperidone—Rash—Etoposide—uterine cancer	0.000191	0.000322	CcSEcCtD
Paliperidone—Dermatitis—Etoposide—uterine cancer	0.000191	0.000322	CcSEcCtD
Paliperidone—Headache—Etoposide—uterine cancer	0.00019	0.00032	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—uterine cancer	0.00019	0.00032	CcSEcCtD
Paliperidone—Tension—Doxorubicin—uterine cancer	0.000189	0.000319	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—uterine cancer	0.000189	0.000318	CcSEcCtD
Paliperidone—Malaise—Epirubicin—uterine cancer	0.000188	0.000316	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—uterine cancer	0.000187	0.000315	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—uterine cancer	0.000187	0.000315	CcSEcCtD
Paliperidone—Syncope—Epirubicin—uterine cancer	0.000187	0.000315	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—uterine cancer	0.000187	0.000314	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—uterine cancer	0.000186	0.000314	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—uterine cancer	0.000185	0.000312	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—uterine cancer	0.000184	0.00031	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—uterine cancer	0.000183	0.000308	CcSEcCtD
Paliperidone—Cough—Epirubicin—uterine cancer	0.000182	0.000306	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—uterine cancer	0.000182	0.000306	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—uterine cancer	0.000181	0.000304	CcSEcCtD
Paliperidone—Nausea—Etoposide—uterine cancer	0.00018	0.000303	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—uterine cancer	0.00018	0.000303	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000179	0.000301	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—uterine cancer	0.000178	0.0003	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—uterine cancer	0.000177	0.000299	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—uterine cancer	0.000177	0.000299	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—uterine cancer	0.000177	0.000299	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—uterine cancer	0.000177	0.000298	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—uterine cancer	0.000177	0.000298	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000176	0.000297	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—uterine cancer	0.000175	0.000295	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—uterine cancer	0.000174	0.000293	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—uterine cancer	0.000173	0.000292	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—uterine cancer	0.000173	0.000292	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—uterine cancer	0.000173	0.000291	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—uterine cancer	0.000173	0.000291	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—uterine cancer	0.000171	0.000289	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—uterine cancer	0.00017	0.000287	CcSEcCtD
Paliperidone—Oedema—Epirubicin—uterine cancer	0.00017	0.000286	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—uterine cancer	0.00017	0.000286	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—uterine cancer	0.000169	0.000285	CcSEcCtD
Paliperidone—Infection—Epirubicin—uterine cancer	0.000169	0.000284	CcSEcCtD
Paliperidone—Cough—Doxorubicin—uterine cancer	0.000168	0.000283	CcSEcCtD
Paliperidone—Shock—Epirubicin—uterine cancer	0.000167	0.000282	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—uterine cancer	0.000167	0.000281	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—uterine cancer	0.000167	0.000281	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—uterine cancer	0.000166	0.00028	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—uterine cancer	0.000166	0.00028	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—uterine cancer	0.000166	0.000279	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—uterine cancer	0.000165	0.000278	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—uterine cancer	0.000164	0.000276	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—uterine cancer	0.000164	0.000276	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—uterine cancer	0.000164	0.000276	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—uterine cancer	0.000164	0.000275	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000163	0.000274	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—uterine cancer	0.000162	0.000273	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—uterine cancer	0.000162	0.000273	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—uterine cancer	0.000161	0.00027	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—uterine cancer	0.000159	0.000268	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—uterine cancer	0.000159	0.000267	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—uterine cancer	0.000157	0.000265	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—uterine cancer	0.000157	0.000265	CcSEcCtD
Paliperidone—Infection—Doxorubicin—uterine cancer	0.000156	0.000263	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000155	0.000261	CcSEcCtD
Paliperidone—Shock—Doxorubicin—uterine cancer	0.000155	0.000261	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—uterine cancer	0.000154	0.00026	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—uterine cancer	0.000154	0.000259	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—uterine cancer	0.000154	0.000259	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—uterine cancer	0.000154	0.000259	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—uterine cancer	0.000153	0.000257	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—uterine cancer	0.000153	0.000257	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—uterine cancer	0.000152	0.000255	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—uterine cancer	0.000151	0.000255	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—uterine cancer	0.00015	0.000253	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—uterine cancer	0.00015	0.000252	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—uterine cancer	0.000148	0.000249	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—uterine cancer	0.000147	0.000248	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000147	0.000247	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—uterine cancer	0.000147	0.000247	CcSEcCtD
Paliperidone—Pain—Epirubicin—uterine cancer	0.000145	0.000245	CcSEcCtD
Paliperidone—Constipation—Epirubicin—uterine cancer	0.000145	0.000245	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000143	0.000241	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—uterine cancer	0.000142	0.00024	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—uterine cancer	0.000141	0.000238	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—uterine cancer	0.00014	0.000236	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—uterine cancer	0.00014	0.000236	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—uterine cancer	0.00014	0.000236	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000139	0.000234	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—uterine cancer	0.000139	0.000233	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—uterine cancer	0.000137	0.00023	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000136	0.000229	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—uterine cancer	0.000136	0.000228	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—uterine cancer	0.000135	0.000227	CcSEcCtD
Paliperidone—Pain—Doxorubicin—uterine cancer	0.000135	0.000227	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—uterine cancer	0.000135	0.000227	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—uterine cancer	0.000134	0.000226	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—uterine cancer	0.000134	0.000226	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—uterine cancer	0.00013	0.000218	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000129	0.000217	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—uterine cancer	0.000125	0.000211	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—uterine cancer	0.000125	0.00021	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—uterine cancer	0.000124	0.000209	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—uterine cancer	0.000124	0.000209	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—uterine cancer	0.000122	0.000205	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—uterine cancer	0.00012	0.000203	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—uterine cancer	0.000116	0.000196	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—uterine cancer	0.000116	0.000195	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—uterine cancer	0.000113	0.00019	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—uterine cancer	0.000112	0.000189	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—uterine cancer	0.000111	0.000187	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—uterine cancer	0.000108	0.000182	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—uterine cancer	0.000108	0.000181	CcSEcCtD
Paliperidone—Rash—Epirubicin—uterine cancer	0.000107	0.000181	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—uterine cancer	0.000107	0.00018	CcSEcCtD
Paliperidone—Headache—Epirubicin—uterine cancer	0.000107	0.000179	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—uterine cancer	0.000104	0.000175	CcSEcCtD
Paliperidone—Nausea—Epirubicin—uterine cancer	0.000101	0.00017	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—uterine cancer	0.0001	0.000168	CcSEcCtD
Paliperidone—Rash—Doxorubicin—uterine cancer	9.92e-05	0.000167	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—uterine cancer	9.91e-05	0.000167	CcSEcCtD
Paliperidone—Headache—Doxorubicin—uterine cancer	9.86e-05	0.000166	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—uterine cancer	9.35e-05	0.000157	CcSEcCtD
